PRVA News and Press, Privia Health Group Inc. From 01/04/22

ARLINGTON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40 th Annual J.P. Morgan Healthcare Conference. The Company’s management team will present a business overview as part of a virtual fireside chat o...

A newly detected coronavirus variant in Africa created panic and sparked a market selloff in the holiday-shortened week. However, the developers of COVID-19 vaccines and therapeutics advanced while several common stock offerings pressured decliners. Despite the outperformance of biotech stock...

Privia Health Group (NASDAQ:PRVA) has priced its public offering of 6M common shares by certain selling stockholders at $29.00/share. Underwriters' over-allotment is an additional 900K shares. Closing date is November 23, 2021. The Company will not receive any proceeds from the secondary offe...

ARLINGTON, Va., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA, or “Privia Health” or the “Company”), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, ann...

Privia Health Group (NASDAQ:PRVA) has announced an underwritten public offering of 6M shares of its common stock by certain selling stockholders. The selling stockholders plan to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares. Privia Health will not rece...

ARLINGTON, Va., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA, or “Privia Health” or the “Company”), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, tod...

The following slide deck was published by Privia Health Group, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Privia Health Group, Inc. 2021 Q3 - Results - Earnings Call Presentation

Privia Health Group (PRVA +13.0%) has recorded its second-biggest intraday gain ever after the company managed to beat consensus estimates for revenue by as much as $36.9M with its Q3 2021 financials. Total revenue for the quarter grew ~21.4% YoY to reach $251.5M, with Practice Collectio...

Privia Health Group, Inc. (PRVA) Q3 2021 Earnings Conference Call November 08, 2021 8:00 AM ET Company Participants Robert Borchert - Senior Vice President of Investor and Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer Da...

Gainers: Autolus Therapeutics AUTL +33%, PetVivo PETV +21%, Cronos (NASDAQ:CRON) +19%, Tenaya Therapeutics (NASDAQ:TNYA) +16%, Privia Health PRVA +13%. Losers: GT Biopharma (NASDAQ:GTBP) -29%, Ontrak (NASDAQ:OTRK) -19%, Molecular Partners...